Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (4)

Search Parameters:
Keywords = medicines in disguise

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 842 KB  
Article
The Occurrence of Illicit Smart Drugs or Nootropics in Europe and Australia and Their Associated Dangers: Results from a Market Surveillance Study by 12 Official Medicines Control Laboratories
by Celine Vanhee, Eric Deconinck, Mark George, Andrew Hansen, Andreas Hackl, Uwe Wollein, Oliver El-Atma, Nico Beerbaum, Federica Aureli, Anna Borioni, Magdalena Poplawska, Agata Blazewicz, Karin Roschel, Claude Marson, Magnolia Mendoza Barrios, Birgit Hakkarainen, Andreas Blomgren, Ingrid Bakker-‘t Hart and Marta Miquel
J. Xenobiotics 2025, 15(3), 88; https://doi.org/10.3390/jox15030088 - 6 Jun 2025
Cited by 6 | Viewed by 20318
Abstract
In recent years, an increasing number of case reports have mentioned the presence of illicit nootropics, smart drugs or mind doping products on the market. To better understand the extent of the problem, a market surveillance study was organised by the General European [...] Read more.
In recent years, an increasing number of case reports have mentioned the presence of illicit nootropics, smart drugs or mind doping products on the market. To better understand the extent of the problem, a market surveillance study was organised by the General European Official Medicines Control Laboratory Network and associated member Australia to detect substandard, falsified or illegal medicines or dietary supplements containing unauthorised nootropic molecules of natural or synthetic origin. From January 2020 to September 2024, 159 different samples were documented, which yielded a comprehensive dataset of 166 molecular identification entries. Within this dataset, 34 distinct molecules were identified. Most samples were sold or presented as dietary supplements (49%) or medicines (32%). The vast majority (69%) were collected from the illegal market. Prescription drugs and non-authorised drugs only available on prescription in Russia were found in pharmacological quantities; some of the latter (noopept, phenylpiracetam and phenibut) were intercepted as large bulk quantities of raw material. Unauthorised novel foods, prescription or higher amounts of melatonin, and clinically uncharacterised research molecules were also reported. This study highlights the need for more active monitoring and screening of such products, as consumption of some of the reported samples could have detrimental health effects. Furthermore, as a large number of the samples were presented as dietary supplements, consumers may not be aware of the possible dangers and side-effects of these products. Full article
(This article belongs to the Section Nutraceutics)
Show Figures

Graphical abstract

19 pages, 2448 KB  
Article
Cross-Analytical Strategies to Tackle “Medicines in Disguise” Presented as Food Supplements, a New Threat for Human Health
by Judith Nzoughet Kouassi, Chouaha Bouzidi, Béatrice Nicolai, Farah Ben Jamaa, Annabelle Dugay, Jérôme Langrand, Dominique Vodovar, Pascal Houzé, Laurence Labat, Bruno Mégarbane, Cinzia Bocca, Pascal Reynier, Nicolas Guiblin, Sylvie Michel and Xavier Cachet
Molecules 2025, 30(6), 1372; https://doi.org/10.3390/molecules30061372 - 19 Mar 2025
Cited by 2 | Viewed by 2426
Abstract
Plant-based food supplements (FS) of doubtful traceability have now emerged as a new threat to human health. Food supplements adulterated with pharmaceutical ingredients are considered “medicines in disguise” by regulatory authorities, which is a sub-category of falsified medicines. In the context of illegal [...] Read more.
Plant-based food supplements (FS) of doubtful traceability have now emerged as a new threat to human health. Food supplements adulterated with pharmaceutical ingredients are considered “medicines in disguise” by regulatory authorities, which is a sub-category of falsified medicines. In the context of illegal manufacture and trade, as well as in the absence of an official phyto- and/or pharmacovigilance system, emergency departments and poison control centers constitute a early warning system for detecting ingested suspect FS. In the present investigation, we set up efficient workflows for the systematic characterization of adulterated plant-based FS in the context of an original local early warning alert system (i.e., FalsiMedTrack) involving an emergency department, a poison center, and academic analytical chemistry laboratories. Fit-for-purpose cross-analytical methods were employed, including sophisticated methods such as liquid chromatography coupled to high-resolution mass spectrometry, nuclear magnetic resonance, X-ray powder diffraction, as well as the most accessible and affordable HPLC method with UV/DAD detection. The strategy was applied successfully to typical cases of suspect plant-based health products, i.e., sample incriminated in patients experiencing side effects and herbal products currently commercialized for their “amazing health benefits”. The samples contained active pharmaceutical ingredients, including diclofenac, piroxicam, dexamethasone 21-acetate, and sibutramine. We provided evidence of “medicines in disguise” presented as food supplements, which raises concerns about their quality and safety. Full article
Show Figures

Graphical abstract

481 KB  
Case Report
Treatment of Giant Cell Tumor of Soft Tissue Disguised as Giant Cell Tumor of the Bone Involving the Distal and Proximal Phalanges of the Great Toe
by Ronika Sethi, Grace Tsai, Wei-Jei Liao and Lawrence Horl
J. Am. Podiatr. Med. Assoc. 2021, 111(6), 20124; https://doi.org/10.7547/20-124 - 1 Nov 2021
Viewed by 109
Abstract
Giant cell tumors are benign tumors that are locally aggressive and rare in the foot. Giant cell tumors involving bone in the foot have an incidence of 1.2% to 2.8%, whereas giant cell tumors of the tendon sheath constitute 3% to 5% of [...] Read more.
Giant cell tumors are benign tumors that are locally aggressive and rare in the foot. Giant cell tumors involving bone in the foot have an incidence of 1.2% to 2.8%, whereas giant cell tumors of the tendon sheath constitute 3% to 5% of all giant cell tumors in the foot and ankle. We present a case of giant cell tumor of the soft tissue disguised as a giant cell tumor of bone in a healthy 29-year-old male patient. Through radiographic and magnetic resonance imaging evaluation, it was determined that this patient had a bone tumor invading the distal and proximal phalanges of his left great toe with the involvement of soft tissue. With the use of the evidence-based medicine and patient expectation, the decision was made to amputate the digit. To much surprise, when the histopathologic results were reviewed, it was determined that the excised lesion was consistent with giant cell tumor of soft tissue that did not involve the bone. Full article
Show Figures

16 pages, 5866 KB  
Article
A Rapid and Nondestructive Approach for the Classification of Different-Age Citri Reticulatae Pericarpium Using Portable Near Infrared Spectroscopy
by Pao Li, Xinxin Zhang, Shangke Li, Guorong Du, Liwen Jiang, Xia Liu, Shenghua Ding and Yang Shan
Sensors 2020, 20(6), 1586; https://doi.org/10.3390/s20061586 - 12 Mar 2020
Cited by 33 | Viewed by 4660
Abstract
Citri Reticulatae Pericarpium (CRP), has been used in China for hundreds of years as a functional food and medicine. However, some short-age CRPs are disguised as long-age CRPs by unscrupulous businessmen in order to obtain higher profits. In this paper, a rapid and [...] Read more.
Citri Reticulatae Pericarpium (CRP), has been used in China for hundreds of years as a functional food and medicine. However, some short-age CRPs are disguised as long-age CRPs by unscrupulous businessmen in order to obtain higher profits. In this paper, a rapid and nondestructive method for the classification of different-age CRPs was established using portable near infrared spectroscopy (NIRS) in diffuse reflectance mode combination with appropriate chemometric methods. The spectra of outer skin and inner capsule of CRPs at different storage ages were obtained directly without destroying the samples. Principal component analysis (PCA) with single and combined spectral pretreatment methods was used for the classification of different-age CRPs. Furthermore, the data were pretreated with the PCA method, and Fisher linear discriminant analysis (FLD) with optimized pretreatment methods was discussed for improving the accuracy of classification. Data pretreatment methods can be used to eliminate the noise and background interference. The classification accuracy of inner capsule is better than that of outer skin data. Furthermore, the best results with 100% prediction accuracy can be obtained with FLD method, even without pretreatment. Full article
(This article belongs to the Special Issue Sensors for Nondestructive Testing and Evaluation)
Show Figures

Graphical abstract

Back to TopTop